AAP
Arax Advisory Partners Portfolio holdings
AUM
$2.18B
1-Year Return
13.41%
This Quarter Return
-0.35%
1 Year Return
+13.41%
3 Year Return
+43.76%
5 Year Return
–
10 Year Return
–
AUM
$1.59B
AUM Growth
+$469M
(+42%)
Cap. Flow
+$481M
Cap. Flow
% of AUM
30.29%
Top 10 Holdings %
Top 10 Hldgs %
26.26%
Holding
2,829
New
215
Increased
1,024
Reduced
629
Closed
414
Top Buys
Top Sells
| 1 |
Vanguard Mid-Cap Value ETF
VOE
|
+$2.95M |
| 2 |
iShares S&P 500 Growth ETF
IVW
|
+$1.47M |
| 3 |
iShares Core High Dividend ETF
HDV
|
+$1.16M |
| 4 |
Schwab US Large-Cap Growth ETF
SCHG
|
+$1M |
| 5 |
Vanguard Intermediate-Term Bond ETF
BIV
|
+$995K |
Sector Composition
| 1 | Technology | 5.92% |
| 2 | Financials | 3.04% |
| 3 | Consumer Discretionary | 2.72% |
| 4 | Healthcare | 2.35% |
| 5 | Industrials | 2.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2051
SI-BONE Inc
SIBN
$704M
| $1.67K | ﹤0.01% |
119
+57
| +92% | +$799 |
|
2052
Torrid Holdings
CURV
$191M
| $1.66K | ﹤0.01% |
317
| – | – |
|
2053
Kohl's
KSS
$1.81B
| $1.66K | ﹤0.01% |
+118
| New | +$1.66K |
|
2054
Driven Brands
DRVN
$3.05B
| $1.65K | ﹤0.01% |
102
-111
| -52% | -$1.79K |
|
|
EVBN
2055
DELISTED
Evans Bancorp Inc
EVBN
| $1.65K | ﹤0.01% |
38
| – | – |
|
2056
Aveanna Healthcare
AVAH
$1.76B
| $1.63K | ﹤0.01% |
357
| – | – |
|
2057
Viant Technology
DSP
$162M
| $1.6K | ﹤0.01% |
84
| – | – |
|
2058
Heron Therapeutics
HRTX
$196M
| $1.58K | ﹤0.01% |
1,035
-60
| -5% | -$92 |
|
2059
Copa Holdings
CPA
$4.82B
| $1.58K | ﹤0.01% |
+18
| New | +$1.58K |
|
2060
Werner Enterprises
WERN
$1.72B
| $1.58K | ﹤0.01% |
44
-268
| -86% | -$9.63K |
|
2061
Malibu Boats
MBUU
$652M
| $1.58K | ﹤0.01% |
42
| – | – |
|
2062
Origin Materials
ORGN
$81.4M
| $1.57K | ﹤0.01% |
1,229
| – | – |
|
2063
Nathan's Famous
NATH
$452M
| $1.57K | ﹤0.01% |
20
| – | – |
|
2064
Larimar Therapeutics
LRMR
$357M
| $1.57K | ﹤0.01% |
405
+119
| +42% | +$461 |
|
2065
AdvanSix
ASIX
$586M
| $1.57K | ﹤0.01% |
+55
| New | +$1.57K |
|
2066
Madison Square Garden
MSGE
$2.06B
| $1.57K | ﹤0.01% |
44
-4
| -8% | -$142 |
|
2067
Liberty Live Group Series C
LLYVK
$9.36B
| $1.57K | ﹤0.01% |
23
+19
| +475% | +$1.29K |
|
2068
NVE Corp
NVEC
$328M
| $1.55K | ﹤0.01% |
+19
| New | +$1.55K |
|
2069
Provident Financial Services
PFS
$2.61B
| $1.54K | ﹤0.01% |
82
-41
| -33% | -$771 |
|
2070
ImmunityBio
IBRX
$2.45B
| $1.54K | ﹤0.01% |
600
-8
| -1% | -$20 |
|
2071
Progyny
PGNY
$1.99B
| $1.54K | ﹤0.01% |
89
+85
| +2,125% | +$1.47K |
|
2072
Guardant Health
GH
$7.08B
| $1.53K | ﹤0.01% |
50
-34
| -40% | -$1.04K |
|
|
MAGN
2073
Magnera Corporation
MAGN
$414M
| $1.53K | ﹤0.01% |
+84
| New | +$1.53K |
|
2074
Hingham Institution for Saving
HIFS
$619M
| $1.53K | ﹤0.01% |
6
| – | – |
|
2075
Axsome Therapeutics
AXSM
$6.14B
| $1.52K | ﹤0.01% |
18
+7
| +64% | +$592 |
|